Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CLP 243.40 trillion. The enterprise value is 275.67 trillion.
| Market Cap | 243.40T |
| Enterprise Value | 275.67T |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Mar 16, 2026 |
Share Statistics
| Current Share Class | 2.47B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 80.17% |
| Float | 2.47B |
Valuation Ratios
The trailing PE ratio is 14.80 and the forward PE ratio is 21.44.
| PE Ratio | 14.80 |
| Forward PE | 21.44 |
| PS Ratio | 4.16 |
| PB Ratio | 5.13 |
| P/TBV Ratio | 62.18 |
| P/FCF Ratio | 21.86 |
| P/OCF Ratio | 16.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.42, with an EV/FCF ratio of 24.76.
| EV / Earnings | 16.77 |
| EV / Sales | 4.73 |
| EV / EBITDA | 10.42 |
| EV / EBIT | 12.58 |
| EV / FCF | 24.76 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.54 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 4.09 |
| Interest Coverage | 18.03 |
Financial Efficiency
Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.
| Return on Equity (ROE) | 36.88% |
| Return on Assets (ROA) | 12.04% |
| Return on Invested Capital (ROIC) | 25.91% |
| Return on Capital Employed (ROCE) | 22.54% |
| Weighted Average Cost of Capital (WACC) | 5.77% |
| Revenue Per Employee | 791.35M |
| Profits Per Employee | 222.20M |
| Employee Count | 75,000 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, Merck & Co. has paid 2.53 trillion in taxes.
| Income Tax | 2.53T |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +53.55% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +53.55% |
| 50-Day Moving Average | 117.45 |
| 200-Day Moving Average | 95.86 |
| Relative Strength Index (RSI) | 69.46 |
| Average Volume (20 Days) | 7 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.48 |
Income Statement
In the last 12 months, Merck & Co. had revenue of CLP 58.56 trillion and earned 16.44 trillion in profits. Earnings per share was 6,557.61.
| Revenue | 58.56T |
| Gross Profit | 45.22T |
| Operating Income | 22.04T |
| Pretax Income | 18.98T |
| Net Income | 16.44T |
| EBITDA | 26.22T |
| EBIT | 22.04T |
| Earnings Per Share (EPS) | 6,557.61 |
Balance Sheet
The company has 13.12 trillion in cash and 45.52 trillion in debt, giving a net cash position of -32,399.80 billion.
| Cash & Cash Equivalents | 13.12T |
| Total Debt | 45.52T |
| Net Cash | -32,399.80B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 47.44T |
| Book Value Per Share | 19,148.71 |
| Working Capital | 13.68T |
Cash Flow
In the last 12 months, operating cash flow was 14.84 trillion and capital expenditures -3,703.97 billion, giving a free cash flow of 11.13 trillion.
| Operating Cash Flow | 14.84T |
| Capital Expenditures | -3,703.97B |
| Depreciation & Amortization | 4.14T |
| Net Borrowing | 10.14T |
| Free Cash Flow | 11.13T |
| FCF Per Share | n/a |
Margins
Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.
| Gross Margin | 77.21% |
| Operating Margin | 37.64% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 44.77% |
| EBIT Margin | 37.64% |
| FCF Margin | 19.01% |
Dividends & Yields
This stock pays an annual dividend of 3,080.85, which amounts to a dividend yield of 2,617.33%.
| Dividend Per Share | 3,080.85 |
| Dividend Yield | 2,617.33% |
| Dividend Growth (YoY) | 3.22% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 44.79% |
| Buyback Yield | 1.34% |
| Shareholder Yield | 2,618.66% |
| Earnings Yield | 6.76% |
| FCF Yield | 4.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.5 |
| Piotroski F-Score | 5 |